Requiem for the 'vulnerable plaque'

Eur Heart J. 2015 Nov 14;36(43):2984-7. doi: 10.1093/eurheartj/ehv349. Epub 2015 Jul 22.

Authors

Peter Libby¹, Gerard Pasterkamp²

Affiliations

¹ Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, USA [email protected] [email protected] [email protected] [email protected].
² Laboratory of Experimental Cardiology and Clinical Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands.

PMID: 26206212
DOI: 10.1093/eurheartj/ehv349

No abstract available

Publication types

Review

MeSH terms

Acute Coronary Syndrome / prevention & control*
Coronary Thrombosis / etiology
Coronary Thrombosis / prevention & control
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Plaque, Atherosclerotic / prevention & control*
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors